A Multicenter, 2 Part Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Rheumatoid Arthritis With Persistently Active Disease
Phase of Trial: Phase IV
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Corticotropin (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Mallinckrodt plc
- 14 Nov 2016 According to a Mallinckrodt plc media release, first patient has been enrolled in the trial.
- 02 Nov 2016 Status changed from not yet recruiting to recruiting.
- 05 Oct 2016 New trial record